{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:52:14Z","timestamp":1792000334719,"version":"4.4.0"},"reference-count":42,"publisher":"American Psychiatric Association Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNP"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1176\/jnp.17.3.324","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T23:14:21Z","timestamp":1418858061000},"page":"324-332","source":"Crossref","is-referenced-by-count":19,"title":["Assessment of Scientific and Ethical Issues in Two Randomized Clinical Trial Designs for Patients With Tourette\u2019s Syndrome: A Model for Studies of Multiple Neuropsychiatric Diagnoses"],"prefix":"10.1176","volume":"17","author":[{"given":"Donald L.","family":"Gilbert","sequence":"first","affiliation":[{"name":"Received August 4, 2004; revised October 6, 2004; accepted October 22, 2004. From the Division of Neurology, Cincinnati Children\u2019s Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio; the Division of Biostatistics and Epidemiology, University of Cincinnati, Cincinnati, Ohio. Address correspondence to Dr. Gilbert, Cincinnati Children\u2019s Hospital Medical Center, ML #2015, 3333 Burnet Ave., Cincinnati, OH 45229-3039; (E-mail.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ralph","family":"Buncher","sequence":"additional","affiliation":[{"name":"Received August 4, 2004; revised October 6, 2004; accepted October 22, 2004. From the Division of Neurology, Cincinnati Children\u2019s Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio; the Division of Biostatistics and Epidemiology, University of Cincinnati, Cincinnati, Ohio. Address correspondence to Dr. Gilbert, Cincinnati Children\u2019s Hospital Medical Center, ML #2015, 3333 Burnet Ave., Cincinnati, OH 45229-3039; (E-mail.)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R00722","doi-asserted-by":"crossref","unstructured":"Brodie MJ, Chadwick DW, Anhut H, et al: Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002; 43:993\u20131000","DOI":"10.1046\/j.1528-1157.2002.45401.x"},{"key":"R00723","doi-asserted-by":"crossref","unstructured":"Hesdorffer DC, Ludvigsson P, Olafsson E, et al: ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004; 61:731\u2013736","DOI":"10.1001\/archpsyc.61.7.731"},{"key":"R00724","doi-asserted-by":"crossref","unstructured":"Franks RP: Psychiatric issues of childhood seizure disorders. Child Adolesc Psychiatr Clin North Am 2003; 12:551\u2013565","DOI":"10.1016\/S1056-4993(03)00029-4"},{"key":"R00725","doi-asserted-by":"crossref","unstructured":"Patten SB, Fridhandler S, Beck CA, et al: Depressive symptoms in a treated multiple sclerosis cohort. Mult Scler 2003; 9:616\u2013620","DOI":"10.1191\/1352458503ms960oa"},{"key":"R00726","doi-asserted-by":"crossref","unstructured":"Patten SB, Metz LM: Depression in multiple sclerosis. Psychother Psychosom 1997; 66:286\u2013292","DOI":"10.1159\/000289150"},{"key":"R00727","doi-asserted-by":"crossref","unstructured":"Taragano FE, Allegri R, Vicario A, et al: A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of \u2018vascular depression\u2019 Int J Geriatr Psychiatry 2001; 16:254\u2013260","DOI":"10.1002\/gps.340.abs"},{"key":"R00728","doi-asserted-by":"crossref","unstructured":"O\u2019Brien JT, Erkinjuntti T, Reisberg B, et al: Vascular cognitive impairment. Lancet Neurol 2003; 2:89\u201398","DOI":"10.1016\/S1474-4422(03)00305-3"},{"key":"R00729","doi-asserted-by":"crossref","unstructured":"Robinson RG: Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003; 54:376\u2013387","DOI":"10.1016\/S0006-3223(03)00423-2"},{"key":"R007210","doi-asserted-by":"crossref","unstructured":"Mindham RH, Marsden CD, Parkes JD: Psychiatric symptoms during l-dopa therapy for Parkinson\u2019s disease and their relationship to physical disability. Psychol Med 1976; 6:23\u201333","DOI":"10.1017\/S0033291700007467"},{"key":"R007211","doi-asserted-by":"crossref","unstructured":"Klaassen T, Verhey FR, Sneijders GH, et al: Treatment of depression in Parkinson\u2019s disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 1995; 7:281\u2013286","DOI":"10.1176\/jnp.7.3.281"},{"key":"R007212","doi-asserted-by":"crossref","unstructured":"Bonelli RM, Wenning GK, Kapfhammer HP: Huntington\u2019s disease: present treatments and future therapeutic modalities. Int Clin Psychopharmacol 2004; 19:51\u201362","DOI":"10.1097\/00004850-200403000-00001"},{"key":"R007213","doi-asserted-by":"crossref","unstructured":"Apter A, Pauls DL, Bleich A, et al: An epidemiologic study of gilles de la Tourette\u2019s syndrome in Israel. Arch Gen Psychiatry 1993; 50:734\u2013738","DOI":"10.1001\/archpsyc.1993.01820210068008"},{"key":"R007214","doi-asserted-by":"crossref","unstructured":"Kurlan R, McDermott MP, Deeley C, et al: Prevalence of tics in schoolchildren and association with placement in special education. Neurology 2001; 57:1383\u20131388","DOI":"10.1212\/WNL.57.8.1383"},{"key":"R007215","doi-asserted-by":"crossref","unstructured":"Freeman RD, Fast DK, Burd L, et al: An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000; 42:436\u2013447","DOI":"10.1017\/S0012162200000839"},{"key":"R007216","doi-asserted-by":"crossref","unstructured":"Tourette Syndrome Study Group: Treatment of ADHD in children with tics. Neurology 2002; 58:527\u2013536","DOI":"10.1212\/WNL.58.4.527"},{"key":"R007217","doi-asserted-by":"crossref","unstructured":"Gilbert DL, Sethuraman G, Sine L, et al: Tourette syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000; 54:1310\u20131315","DOI":"10.1212\/WNL.54.6.1310"},{"key":"R007219","doi-asserted-by":"crossref","unstructured":"Eapen V, Trimble MR, Robertson MM: The use of fluoxetine in gilles de la Tourette syndrome and obsessive compulsive behaviours: preliminary clinical experience. Prog Neuropsychopharmacol Biol Psychiatry 1996; 20:737\u2013743","DOI":"10.1016\/0278-5846(96)00044-9"},{"key":"R007220","doi-asserted-by":"crossref","unstructured":"Anca MH, Giladi N, Korczyn AD: Ropinirole in gilles de la Tourette syndrome. Neurol 2004; 62:1626\u20131627","DOI":"10.1212\/01.WNL.0000123111.00324.BF"},{"key":"R007221","doi-asserted-by":"crossref","unstructured":"Bruun RD, Budman CL: Paroxetine treatment of episodic rages associated with Tourette\u2019s disorder. J Clin Psychiatry 1998; 59:581\u2013584","DOI":"10.4088\/JCP.v59n1104"},{"key":"R007222","doi-asserted-by":"crossref","unstructured":"Chappell PB, Riddle MA, Scahill L, et al: Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette\u2019s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1995; 34:1140\u20131146","DOI":"10.1097\/00004583-199509000-00010"},{"key":"R007223","doi-asserted-by":"crossref","unstructured":"Dursun SM, Reveley MA: Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette\u2019s syndrome: an open study. Psychol Med 1997; 27:483\u2013487","DOI":"10.1017\/S0033291796003984"},{"key":"R007224","doi-asserted-by":"crossref","unstructured":"McConville BJ, Fogelson MH, Norman AB, et al: Nicotine potentiation of haloperidol in reducing tic frequency in Tourette\u2019s disorder [published erratum appears in Am J Psychiatry 1991; 148(9):1282] [see comments]. Am J Psychiatry 1991; 148:793\u2013794","DOI":"10.1176\/ajp.148.6.793"},{"key":"R007225","doi-asserted-by":"crossref","unstructured":"Jankovic J: Deprenyl in attention deficit associated with Tourette\u2019s syndrome. Arch Neurol 1993; 50:286\u2013288","DOI":"10.1001\/archneur.1993.00540030052014"},{"key":"R007226","doi-asserted-by":"crossref","unstructured":"Silver AA, Shytle RD, Sanberg PR: Mecamylamine in Tourette\u2019s syndrome: a two-year retrospective case study. J Child Adolesc Psychopharmacol 2000; 10:59\u201368","DOI":"10.1089\/cap.2000.10.59"},{"key":"R007227","doi-asserted-by":"crossref","unstructured":"Peterson BS, Leckman JF, Scahill L, et al: Steroid hormones and Tourette\u2019s syndrome: early experience with antiandrogen therapy. J Clin Psychopharmacol 1994; 14:131\u2013135","DOI":"10.1097\/00004714-199404000-00008"},{"key":"R007228","doi-asserted-by":"crossref","unstructured":"Stamenkovic M, Schindler SD, Aschauer HN, et al: Effective open-label treatment of Tourette\u2019s disorder with olanzapine. Int Clin Psychopharmacol 2000; 15:23\u201328","DOI":"10.1097\/00004850-200015010-00003"},{"key":"R007229","doi-asserted-by":"crossref","unstructured":"Toren P, Laor N, Cohen DJ, et al: Ondansetron treatment in patients with Tourette\u2019s syndrome. Int Clin Psychopharmacol 1999; 14:373\u2013376","DOI":"10.1097\/00004850-199911000-00008"},{"key":"R007230","doi-asserted-by":"crossref","unstructured":"Koller W, Lees A, Doder M, et al: Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson\u2019s disease patients with motor fluctuations. Mov Disord 2001; 16:858\u2013866","DOI":"10.1002\/mds.1175"},{"key":"R007231","doi-asserted-by":"crossref","unstructured":"McIntyre RS, Mancini DA, McCann S, et al: Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disorders 2002; 4:207\u2013213","DOI":"10.1034\/j.1399-5618.2002.01189.x"},{"key":"R007232","doi-asserted-by":"crossref","unstructured":"Pappert EJ, Goetz CG, Louis ED, et al: Objective assessments of longitudinal outcome in gilles de la Tourette\u2019s syndrome. Neurol 2003; 61:936\u2013940","DOI":"10.1212\/01.WNL.0000086370.10186.7C"},{"key":"R007233","doi-asserted-by":"crossref","unstructured":"Snider LA, Seligman LD, Ketchen BR, et al: Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 2002; 110:331\u2013336","DOI":"10.1542\/peds.110.2.331"},{"key":"R007234","doi-asserted-by":"crossref","unstructured":"Gilbert DL, Bansal AS, Sethuraman G, et al: Association of cortical disinhibition with tic, adhd, and OCD severity in Tourette syndrome. Mov Disord 2004; 19:416\u2013425","DOI":"10.1002\/mds.20044"},{"key":"R007235","doi-asserted-by":"crossref","unstructured":"Moher D, Schulz KF, and Altman DG: The consort statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. [see comment]. Lancet 2001; 357:1191\u20131194","DOI":"10.1016\/S0140-6736(00)04337-3"},{"key":"R007236","doi-asserted-by":"crossref","unstructured":"Wasson J, Gaudette C, Whaley F, et al: Telephone care as a substitute for routine clinic follow-up. [see comment]. JAMA 1992; 267:1788\u20131793","DOI":"10.1001\/jama.267.13.1788"},{"key":"R007237","doi-asserted-by":"crossref","unstructured":"Bornstein RA, Stefl ME, and Hammond L: A survey of Tourette syndrome patients and their families: the 1987 ohio Tourette survey. J Neuropsychiatry Clin Neurosci 1990; 2:275\u2013281","DOI":"10.1176\/jnp.2.3.275"},{"key":"R007238","doi-asserted-by":"crossref","unstructured":"Gaffney GR, Perry PJ, Lund BC, et al: Risperidone versus clonidine in the treatment of children and adolescents with Tourette\u2019s syndrome. J Am Acad Child Adolesc Psychiatry 2002; 41:330\u2013336","DOI":"10.1097\/00004583-200203000-00013"},{"key":"R007239","doi-asserted-by":"crossref","unstructured":"Sallee FR, Nesbitt L, Jackson C, et al: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette\u2019s disorder. Am J Psychiatry 1997; 154:1057\u20131062","DOI":"10.1176\/ajp.154.8.1057"},{"key":"R007240","doi-asserted-by":"crossref","unstructured":"Shapiro E, Shapiro AK, Fulop G, et al: Controlled study of haloperidol, pimozide and placebo for the treatment of gilles de la Tourette\u2019s syndrome. Arch Gen Psychiatry 1989; 46:722\u2013730","DOI":"10.1001\/archpsyc.1989.01810080052006"},{"key":"R007241","doi-asserted-by":"crossref","unstructured":"Bruggeman R, van dL, Buitelaar JK et al: Risperidone versus pimozide in Tourette\u2019s disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001; 62:50\u201356","DOI":"10.4088\/JCP.v62n0111"},{"key":"R007242","doi-asserted-by":"crossref","unstructured":"Gilbert DL, Batterson JR, Sethuraman G, et al: Tic reduction with risperidone vs. pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 2004; 43:206\u2013214","DOI":"10.1097\/00004583-200402000-00017"},{"key":"R007243","doi-asserted-by":"crossref","unstructured":"Castellanos FX, Giedd JN, Elia J, et al: Controlled stimulant treatment of ADHD and comorbid Tourette\u2019s syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 1997; 36:589\u2013596","DOI":"10.1097\/00004583-199705000-00008"},{"key":"R007244","doi-asserted-by":"crossref","unstructured":"Singer HS, Brown J, Quaskey S, et al: The treatment of attention-deficit hyperactivity disorder in Tourette\u2019s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995; 95:74\u201381","DOI":"10.1542\/peds.95.1.74"}],"container-title":["The Journal of Neuropsychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/jnp.17.3.324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T23:42:01Z","timestamp":1722382921000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/jnp.17.3.324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1176\/jnp.17.3.324"],"URL":"https:\/\/doi.org\/10.1176\/jnp.17.3.324","relation":{},"ISSN":["0895-0172","1545-7222"],"issn-type":[{"value":"0895-0172","type":"print"},{"value":"1545-7222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}